ReviR Therapeutics
About:
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Website: http://www.revirtx.com
Top Investors: XtalPi, CDH Investments, Sky9 Capital, Shunwei Capital, CMT Research Foundation
Description:
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs. Its RNA therapeutics treat cancer, rare genetic disorders, and infectious diseases. It also develops an AI-based and computation-empowered platform to discover RNA-targeting therapeutics.
Total Funding Amount:
$50M
Headquarters Location:
Brisbane, California, United States
Founded Date:
2021-01-01
Founders:
Peng Yue, Yang Li
Number of Employees:
11-50
Last Funding Date:
2024-07-26
IPO Status:
Private
Industries:
© 2025 bioDAO.ai